分化型甲状腺癌首次手术规范与否对再次手术的影响

Abstract
Figure/Table
References (15)
Related Citation (2)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the influence of whether or not the first operation is standard for differentiated thyroid cancer on the second operation.Methods A retrospective analysis of the clinical data of 200 patients with differentiated thyroid cancer admitted to Ningde Hospital of Fujian Province from January 2019 to January 2020 was made.All patients received reoperation.According to the standard of the first operation,they were divided into two groups.The control group (n=100) was the non-standard operation group,and the observation group (n=100) was the standard operation group.Statistical analysis was performed on the patient′s disease recurrence,operation time,drainage time,invasion of surrounding tissues and incidence of complications.Results The recurrence rate of the observation group was lower than that of the control group,and the difference was statistically significant (P<0.05).The operation time and drainage time of the observation group were shorter than those of the control group,and the differences were statistically significant (P<0.05).There was no statistically significant difference in the violation of surrounding tissues between the two groups (P＞0.05).The total incidence of complications in the observation group was lower than that in the control group,and the difference was statistically significant (P＞0.05).Conclusion If the first operation for differentiated thyroid cancer is not standardized,it will increase the patient′s disease recurrence rate and increase the patient′s risk of reoperation.In order to improve the surgical treatment effect,it is necessary to standardize the first operation method and ensure the quality of surgical treatment.

Key words： Differentiated thyroid cancer First operation specification Second operation

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GUAN Yun-zhu

Cite this article:

GUAN Yun-zhu. Influence of whether or not the first operation of differentiated thyroid cancer is performed on the second operation[J]. 中国当代医药, 2021, 28(4): 102-104转111.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I4/102

[1]	燕树勋,刘元炜,王颖,等.分化型甲状腺癌术后中西医研究进展[J].世界中医药，2020，15（10）：1505-1508.
[2]	张俊丽.首次131I 治疗对分化型甲状腺癌手术患者涎腺功能的影响[J].中国药物与临床，2019，19（20）：3604-3606.
[3]	吴昕,李秉璐,郑朝纪,等.分化型甲状腺癌再次手术组织病理阴性的原因分析[J].协和医学杂志，2020，11（4）：425-429.
[4]	廖宁，张玲丽，毛树怿.分化型甲状腺癌手术后首次131I 清除残余甲状腺组织的疗效及影响因素分析[J].标记免疫分析与临床，2015，22（5）：422-423，427.
[5]	向甜，石光清，邱娟，等.手术后分化型甲状腺癌患者首次131I 清除残余甲状腺组织的治疗疗效分析[J].中国医师杂志，2015，17（7）：978-980.
[6]	彭庆，郑容，耿建华，等.131I 治疗分化型甲状腺癌功能性肺转移的短期疗效评价及其影响因素[J].中国医学装备，2020，17（6）：86-91.
[7]	张瑞坚，刘立衡，刘巧爱，等.颈部超声联合甲状腺球蛋白检查对分化性甲状腺癌术后复发诊断的临床价值[J].中国现代普通外科进展，2019，22（7）：515-517.
[8]	杨超，王萌.分化型甲状腺癌骨转移的危险因素分析[J].实用癌症杂志，2019，34（5）：815-817.
[9]	毛雨，任浩宇，胡代星，等.222例分化型甲状腺癌再手术的临床分析[J].中国肿瘤外科杂志，2019，11（2）：121-124.
[10]	李雪蓉，肖雄，张晶晶，等.分化型甲状腺癌术后131I 清甲治疗前血清促甲状腺激素水平最佳区间的确定[J].实用医学杂志，2019，35（15）：2456-2459.
[11]	席雪华，高琼，张波.超声评估持续/复发及转移性分化型甲状腺癌的研究进展[J].北京医学，2018，40（11）：1064-1066，1069.
[12]	吴文澜，王玥，赵炎斌，等.分化型甲状腺癌患者不规范手术后再手术的临床分析[J].肿瘤预防与治疗，2019，32（12）：1106-1112.
[13]	吴昕，徐协群，郑朝纪，等.分化型甲状腺癌再次手术的临床分析[J].中国普外基础与临床杂志，2017，24（7）：813-818.
[14]	李春华，王朝晖，陈锦，等.分化型甲状腺癌再手术的并发症预防[J].中华内分泌外科杂志，2017，11（4）：294-295，315.
[15]	邵礼成，菅洪健，陈广辉，等.中青年分化型甲状腺癌患者术后复发与生存分析[J].南方医科大学学报，2017，37（2）：274-277.